Search

everythinglearnresearchcommunity

for

Search:↓

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Nanoemulsions improve stability and delivery of active ingredients in cosmetics for skin and hair care.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Depigmented hair regrowth after alopecia areata can be permanent.

Nanotechnology improves minoxidil treatment for hair loss.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The transfollicular route shows promise for noninvasive, targeted drug delivery but needs more research.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Mast cells might contribute to hair loss by causing skin thickening.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Topical melatonin and brushing did not affect hair regrowth in Siberian Huskies.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Formulation P-08-016 better targets hair follicles for baldness treatment.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.